Mid-Term Evaluation Of A Monofocal Plus, Intermediate Vision Enhanced Iol (Tecnis Eyhance®): A Real-World Clinical Study With Comparison Of 18-Month And 4-Week Results

Ambispective, non-comparative, single-center study

We conducted an ambispective study on 41 patients who received TECNIS Eyhance® IOL implants in both eyes 18 months or more after undergoing phacoemulsification for cataract at our hospital between September 2020 and September 2021. We retrieved preoperative and 4-week postoperative clinical data from patient records, including distance-corrected intermediate visual acuity, corrected and uncorrected distance visual acuity, uncorrected intermediate visual acuity, manifest refraction, and slit lamp findings. Patient-reported outcomes were obtained using PRISQ and a custom questionnaire. The same data were collected 18 months or more after the surgery.

After four weeks post-surgery, the following mean visual acuity measurements were recorded binocularly: UDVA was 0.05 (median 0.00, range -0.10-0.30), CDVA was 0.02 (median 0.00, range -0.10-0.20), UIVA was 0.16 (median 0.20, range -0.20-0.60), and DCIVA was 0.12 (median 0.10, range -0.10-0.50). 92% of patients were able to work at a computer screen without glasses, and 66% could read books without glasses. Results from the 18-month follow-up will be presented and compared to the 4-week results.